Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for bleeding reduction during tonsillectomy
IRCT20210923052559N3Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in postoperative hemorrhage and Not applicable (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Amount of bleeding. Started Dec 2023; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postoperative hemorrhageNot applicable
Beyond the preview
Go deeper on IRCT20210923052559N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210923052559N3.